186 related articles for article (PubMed ID: 36937919)
1. Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in
Wang X; Yang X; Lu W; Pan L; Han Z; Pan S; Shan Y; Wang X; Zheng X; Li R; Zhu Y; Qin P; Shi Q; Zhou S; Zhang W; Guo S; Zhang P; Qin X; Sun G; Qin Z; Huang Z; Qiu C
Front Cardiovasc Med; 2023; 10():1045859. PubMed ID: 36937919
[TBL] [Abstract][Full Text] [Related]
2. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F
Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions.
Yang X; Lu W; Pan L; Han Z; Pan S; Wang X; Zhu Y; Shan Y; Peng M; Qin P; Zhang P; Qin X; Sun G; Qin Z; Dong J; Qiu C
Front Cardiovasc Med; 2022; 9():935263. PubMed ID: 36211569
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
5. Efficacy of Drug-Coated Balloon Approaches for
Zhong PY; Ma Y; Shang YS; Niu Y; Bai N; Wang ZL
Front Cardiovasc Med; 2022; 9():899701. PubMed ID: 35800174
[TBL] [Abstract][Full Text] [Related]
6. Short-term outcomes of drug-coated balloon versus drug-eluting stent for
Lin L; Lu W; Wang X; Pan L; Wang X; Zheng X; Li R; Shan Y; Peng M; Qiu C
Front Cardiovasc Med; 2023; 10():982880. PubMed ID: 36950290
[TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease.
Shin ES; Jun EJ; Kim S; Kim B; Kim TH; Sohn CB; Her AY; Park Y; Cho JR; Jeong YH; Choi BJ
JACC Cardiovasc Interv; 2023 Feb; 16(3):292-299. PubMed ID: 36609038
[TBL] [Abstract][Full Text] [Related]
8. Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients.
Funayama N; Muratsubaki S; Ito R; Tobisawa T; Konishi T
Heart Vessels; 2023 Mar; 38(3):300-308. PubMed ID: 36045267
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Efficacy and Safety Between Drug-Coated Balloons Versus Drug-Eluting Stents in the Treatment of De Novo Coronary Lesions in Large Vessels: A Study-Level Meta-Analysis of Randomized Control Trials.
Sun B; Zhang XT; Chen RR
Cardiovasc Drugs Ther; 2023 Nov; ():. PubMed ID: 37999833
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Clinical Outcomes of Drug-Coated Balloon Treatment for De Novo Coronary Lesions.
Her AY; Kim B; Ahn SH; Park Y; Cho JR; Jeong YH; Shin ES
Yonsei Med J; 2023 Jun; 64(6):359-365. PubMed ID: 37226562
[TBL] [Abstract][Full Text] [Related]
12. Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial.
Cortese B; Di Palma G; Guimaraes MG; Piraino D; Orrego PS; Buccheri D; Rivero F; Perotto A; Zambelli G; Alfonso F
JACC Cardiovasc Interv; 2020 Dec; 13(24):2840-2849. PubMed ID: 33248978
[TBL] [Abstract][Full Text] [Related]
13. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
[TBL] [Abstract][Full Text] [Related]
14. [Outcomes of patients treated with drug-coated balloons for de novo large coronary vessels].
Qiu J; Han ZY; Wang X; Lu WJ; Pan L; Sun GJ; Qin XF; Wang ZB; Liu GH; Wang XL; Qiu CG
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jun; 47(6):452-456. PubMed ID: 31262129
[No Abstract] [Full Text] [Related]
15. Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents.
Sim HW; Ananthakrishna R; Chan SP; Low AF; Lee CH; Chan MY; Tay EL; Loh PH; Chan KH; Tan HC; Loh JP
J Invasive Cardiol; 2018 Jul; 30(7):256-261. PubMed ID: 29656281
[TBL] [Abstract][Full Text] [Related]
16. Optimal Intraluminal Drug-Coated Balloon Versus Drug-Eluting Stent in Patients With Chronic Total Occlusion of the Superficial Femoral Artery: A Retrospective Analysis.
Hayakawa N; Kodera S; Takanashi K; Kanagami T; Ichihara S; Arakawa M; Hirano S; Inoguchi Y; Shakya S; Kanda J
Cardiovasc Revasc Med; 2022 Oct; 43():87-96. PubMed ID: 35469761
[TBL] [Abstract][Full Text] [Related]
17. Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease.
Her AY; Shin ES; Kim S; Kim B; Kim TH; Sohn CB; Choi BJ; Park Y; Cho JR; Jeong YH
Cardiovasc Diabetol; 2023 May; 22(1):120. PubMed ID: 37210516
[TBL] [Abstract][Full Text] [Related]
18. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
19. Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial.
Scheller B; Ohlow MA; Ewen S; Kische S; Rudolph TK; Clever YP; Wagner A; Richter S; El-Garhy M; Böhm M; Degenhardt R; Mahfoud F; Lauer B
EuroIntervention; 2020 Apr; 15(17):1527-1533. PubMed ID: 31659986
[TBL] [Abstract][Full Text] [Related]
20. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
Wöhrle J; Scheller B; Seeger J; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger RV;
JACC Cardiovasc Interv; 2021 Aug; 14(16):1789-1798. PubMed ID: 34412797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
